Dr. Agarwal’s Health Care has released its Monitoring Agency Report for the quarter ended September 30, 2025 (Q2 FY2026). ICRA Limited, the monitoring agency, confirms that the utilization of IPO proceeds aligns with the company’s stated objectives. The report, dated October 30, 2025, shows no deviations in the use of funds and highlights the deployment of unutilized proceeds in fixed deposits.
IPO Proceeds Utilization
The Monitoring Agency Report confirms that there are no deviations from the intended use of IPO proceeds. All utilizations are in line with the disclosures made in the Offer Document.
Key Financials
As of September 30, 2025:
- Issue Related Expenses: ₹12.380 Crore utilized during the quarter, with a total unutilized amount of ₹15.154 Crore.
- General Corporate Purposes: ₹49.656 Crore has been utilized to date, leaving an unutilized balance of ₹27.810 Crore.
- Repayment/prepayment of Borrowings: ₹195.000 Crore already utilized.
Deployment of Unutilized Proceeds
Unutilized funds have been strategically invested in fixed deposits to maximize returns. Here’s a snapshot of the investments:
- Fixed Deposits across Yes Bank, Axis Bank, UCO Bank and Bajaj Finance Limited yielding returns ranging from 5.80% to 6.50%.
- Total investment in these deposits amounts to ₹53.581 Crore with total earnings of ₹0.434 Crore.
Object Implementation Timeline
The company confirms that both the repayment/prepayment of borrowings and the general corporate purposes are on schedule as per the initial timeline.
Source: BSE